Immunovant Inc
Immunovant Inc (IMVT) Covered Calls
As of September 25, 2026, IMVT has 87 covered call opportunities in the coming three months. Return ranges from 2.9 to 100.0% until expiration. Annualized return ranges from 27.7 to 397.7%. The nearest expiration is October 16, 2026. Maximum potential profit is $3,400.
Read more
Running IMVT covered calls helps you generate consistent income from Immunovant Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Immunovant Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best IMVT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if IMVT stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling IMVT covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Immunovant Inc covered call is worth writing.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Income-focused investors, long-term IMVT holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling IMVT covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Immunovant Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile51.98% Neutral
- Market cap (M$)6,917
- 52 weeks high-26.27%
- 52 weeks low111.83%
- Analyst recommendationStrong Buy
1.47 - Target price$48.88
45.95% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-2.81
- EPS growth next 5 years12.21%
As of September 25, 2026
| 2026-10-16 | 22 | 42.00 | 23.53 | 0.15 | 2.50 | 815.00 | 23.97 | 397.69 | -0.44 | +0.27 | 36 | 2.35 |
| 2026-10-16 | 22 | 40.00 | 17.65 | 0.40 | 1.40 | 640.00 | 18.82 | 312.30 | -1.18 | +0.24 | 62 | 1.00 |
| 2027-01-15 | 113 | 55.00 | 61.76 | 1.10 | 1.95 | 2210.00 | 65.00 | 209.96 | -3.24 | +0.21 | 5 | 0.85 |
| 2026-12-18 | 85 | 50.00 | 47.06 | 0.05 | 3.40 | 1605.00 | 47.21 | 202.71 | -0.15 | +0.25 | 25 | 3.35 |
| 2027-03-19 | 176 | 65.00 | 91.18 | 1.55 | 3.30 | 3255.00 | 95.74 | 198.54 | -4.56 | +0.25 | 4 | 1.75 |
| 2026-12-18 | 85 | 49.00 | 44.12 | 0.15 | 2.60 | 1515.00 | 44.56 | 191.34 | -0.44 | +0.22 | 50 | 2.45 |
| 2027-03-19 | 176 | 60.00 | 76.47 | 1.90 | 4.30 | 2790.00 | 82.06 | 170.18 | -5.59 | +0.30 | 3 | 2.40 |
| 2026-12-18 | 85 | 47.00 | 38.24 | 0.35 | 3.50 | 1335.00 | 39.26 | 168.61 | -1.03 | +0.28 | 0 | 3.15 |
| 2026-10-16 | 22 | 37.00 | 8.82 | 0.40 | 1.65 | 340.00 | 10.00 | 165.91 | -1.18 | +0.32 | 39 | 1.25 |
| 2027-01-15 | 113 | 50.00 | 47.06 | 1.10 | 2.55 | 1710.00 | 50.29 | 162.45 | -3.24 | +0.26 | 44 | 1.45 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best IMVT covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→